# A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly

> **NCT02245620** · PHASE2 · COMPLETED · sponsor: **Stealth BioTherapeutics Inc.** · enrollment: 41 (actual)

## Conditions studied

- Skeletal Muscle Mitochondrial Dysfunction in the Elderly

## Interventions

- **DRUG:** Elamipretide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02245620
- **Lead sponsor:** Stealth BioTherapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-15
- **Primary completion:** 2016-07-06
- **Final completion:** 2016-07-06
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2020-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02245620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02245620, "A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02245620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*